Delivery Order SPE2DB22D1017-SPE2DB25FG4EU
Award Date 6/4/25
Potential Completion Date 6/5/25
Potential Value $6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,024.78 to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (100-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order represents a non-competitive set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication commonly used in military and...
- The Defense Logistics Agency awarded a delivery order valued at $12,027.50 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at the contractor's facility in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication used to prevent organ...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for CellCept 500 mg tablets (500-count packages) valued at $12,029.30 under a firm fixed-price contract type. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through December 2026. CellCept (mycophenolate mofetil) is an...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,014.65 to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (500-count packages) on August 7, 2025, with a completion date of August 8, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle (SPE2DX) that extends through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,577.14 to AmerisourceBergen Drug Corp for the supply of CellCept 250 mg capsules (100 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 mg CellCept tablets (500-count units) valued at $44,285.82 with a firm fixed price structure. The delivery order, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a competitive award with no set-aside designation. Performance will be executed at the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (500-count units) valued at $14,887.62 under a firm fixed-price contract. The award, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery order executed without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its Corporate Office location,...
- The Defense Logistics Agency awarded a $14,353.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500 count) on May 30, 2025, with completion scheduled for June 2, 2025. This delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for CellCept 500 mg tablets (100 count) valued at $1,283.84, with an award date of August 13, 2025, and ultimate completion by August 14, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through...
- The Defense Logistics Agency awarded a $3,611.49 delivery order to AmerisourceBergen Drug Corp for 100 tablets of CellCept 500 mg, an immunosuppressant medication commonly prescribed to prevent organ rejection in transplant patients and treat certain autoimmune conditions. The contract was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, and represents a firm fixed price delivery order with no set-aside designation. The award was executed at the vendor's...